DV
Dividend Vision

TMCI — Treace Medical Concepts Inc

Treace Medical Concepts Inc (TMCI)

Total return is -81.2% over the past 5.3 years, 181.2 points behind SPY at 100.0%. Its deepest 1-year drawdown was 84.4%.

TMCI is an equity stock fund focused on Treace Medical Concepts Inc, a medical device company. The fund provides direct exposure to a single publicly traded company rather than a diversified portfolio. Limited data is available regarding distribution frequency, yield profile, and expense ratio, making this more suitable for investors seeking concentrated exposure to the medical device sector rather than those pursuing traditional dividend income strategies.

TMCI key facts

Asset type
Stock
Asset class
Equity
Inception date
04/23/2021
Last close
$4.79
Market cap
$274,412,704
Average volume
245390.0
Beta
1.378
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.94